GC Biopharma

About GC Biopharma

GC Biopharma is a leading global biopharmaceutical company dedicated to improving lives through innovative solutions. With over 55 years of experience, we specialize in developing and manufacturing plasma derivatives, vaccines, and therapies for rare diseases, alongside offering comprehensive CMO services. 

#GreenCross #Plasma Derivatives #Vaccines #Rare Diseases #Cutting-edge Technology #Global Compliance

As a dominant leader in the Korean plasma derivatives market, GC Biopharma provides a range of high-quality plasma-derived products, ensuring the highest safety an...

Certifications
  • KR
  • 2022
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Primary activities
Biopharmaceutical
Contract Manufacturer
Contact info
  • 107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, 16924, Gyeonggi-do, Korea, Republic Of
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from GC Biopharma (8)

  • Biologic drug product CMO services - Fill and Finish

    Product Biologic drug product CMO services - Fill and Finish

    GC Biopharma is one of the top-tier biopharmaceutical companies in South Korea with over 55 years of history and advanced technology. GC Biopharma provides premium Fill & Finish service to clinical and commercial customers for vaccines, recombinant and biosimilar pharmaceutical products. We have state-of-t...
  • Barycela

    Product Barycela

    "World’s 1st Antibiotic-free varicella vaccine" • WHO PQ vaccine  • Improved stability with automatic and aseptic process • Over the past 28 years, + 28 M doses provided • Exported more than 30 countires
    • Generic name: Varicella Vaccine • Indication: For prophylaxis against varicella • Pr...
  • GC Flu

    Product GC Flu

    "Top 5 global flu vaccine manufacturer" • WHO PQ vaccine • Largest flu vaccine supplier to PAHO & Unicef
    • + 30 M doses supplied worldwide • Generic name: Seasonal Influenza vaccine • Indication: For prophylaxis against influenza • Presentation: 0.5 mL(PFS) 0.25 mL(PFS) 0.5 mL (vial)...
  • I.V-Globulin SN inj.

    Product I.V-Globulin SN inj.

    "A dominant leader of Korea since 1970" • 611 mil liters of IVIG distriubuted worldwide • Distributed in more than 30 countries • High qualtiy IVIG available in 2 strengths(5%, 10%) • Generic Name: Human Normal Immuoglobulin for Intravenous Administration 5% • Presentation: 50 mL, 100 mL, 20...
  • Alyglo

    Product Alyglo

    "U.S Approval in 2023Succeful lunching in 2024"
    • Less contaminants. More purity • Produced with cation exchange(CEX) chromatography, which results in extra-purified IVIG • Generic name: Human Normal Immunoglobulin for Intravenous Administration, 10%
  • Hunterase ICV

    Product Hunterase ICV

    "World's 1st ERT for Neuronopathic MPS II"
    • Direct delivery to the ventricle • Long dosing interval (once a month) • Reduces GAG concentration in the CSF • Generic name: Idursulfase-beta • Indication: Neuronopathic Mucopolysaccharidosis type II (Hunter syndrome) as an enzyme replacement therapy...
  • Hunterase

    Product Hunterase

    "New opportunity for MPS II (Hunter syndrome), ERT" • World's 2nd ERT for MPS II • Serum-Free production process • High Proportion of Active-Form Enzymes • Generic name: Idursulfase-beta • Indication: Mucopolysaccharidosis type II (Hunter syndrome) as an enzyme replacement therapy(ERT) • Presentatio...
  • CMO(CDMO)

    Product CMO(CDMO)

    “Your CMO partner of choice, providing a seamless manufacturing experience tailored to each client” 
    • 50+ Years Track Record • FDA, ANVISA, WHO PQ certification • Clinical & Commercial Aseptic Filling  • Isolator Filling Line (2R, 3R, 6R, 10R, 20R, 30R)  • Fully Automated Visual...

GC Biopharma Resources (9)